GS967
GS967 (GS-458967) is a potent, and selective inhibitor of cardiac late sodium current (late INa) with IC50 values of 0.13 and 0.21 μM for ventricular myocytes and isolated hearts, respectively.
Product Specifications
CAS Number
1262618-39-2
UNSPSC
12352005
Hazard Statement
H302, H315, H320, H335
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/GS967.html
Concentration
10mM
Purity
99.55
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC(C1=NN=C2C=CC(C3=CC=C(OC(F)(F)F)C=C3)=CN21)(F)F
Molecular Formula
C14H7F6N3O
Molecular Weight
347.22
Precautions
H302, H315, H320, H335
References & Citations
[1]Belardinelli L, et al. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J Pharmacol Exp Ther. 2013 Jan;344 (1) :23-32.|[2]Potet F, et al. Use-Dependent Block of Human Cardiac Sodium Channels by GS967. Mol Pharmacol. 2016 Jul;90 (1) :52-60.|[3]Bonatti R, et al. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity. Heart Rhythm. 2014 Oct;11 (10) :1827-35.|[4]Wei X, et al. Pre- and Delayed Treatments With Ranolazine Ameliorate Ventricular Arrhythmias and Nav1.5 Downregulation in Ischemic/Reperfused Rat Hearts. J Cardiovasc Pharmacol. 2016 Oct;68 (4) :269-279.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041266-500 1x 500 µL
Cytokeratin 8 (KRT8) (B22.1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
MC08F-PAG 10x 96 Well Plates
Protein A/G Coated - 96 well Solid plates - Clear PS
Sign In for Pricing
View Details